---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-000514"
form_type: "8-K"
ticker: "SINT"
cik: "0001269026"
company_name: "Sintx Technologies, Inc."
filed_at: "2024-01-04T23:59:59+00:00"
generated_at: "2026-06-07T03:50:07.557945+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# SINTX strengthens antipathogenic patent portfolio with six US and three foreign patents in 2023

## Summary
- Granted six US patents in the last year covering silicon nitride applications: antifungals, antibacterial implants, SARS-CoV-2 inactivation, antiviral compositions, antipathogenic face masks.
- Also received three foreign patents in 2023; 43 patent applications pending worldwide including in US, Asia, Europe, Brazil.
- Patents support commercialization of silicon nitride in agriculture, dentistry, medical implants, durable medical equipment, and PPE.
- NIH-funded commercialization work is ongoing based on coating and composite technologies covered by these patents.

## SEC filing metadata
- accession: 0001493152-24-000514
- form_type: 8-K
- ticker: SINT
- cik: 0001269026
- company_name: Sintx Technologies, Inc.
- filed_at: 2024-01-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1269026/000149315224000514/0001493152-24-000514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1269026/000149315224000514/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-000514
- JSON: https://secwatch.observer/filing/0001493152-24-000514.json
- Plain text: https://secwatch.observer/filing/0001493152-24-000514.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.